ghk-cu clinical trial human Frontiers HC-GHK-CU
Description
The chemical name is -(5,6-dimethylbenzimidazoly) hydroxocobamide

This shouldn't take more than a minute or two

One particular study indicated that GHK-Cu might decrease iron release by 87%, which might lower oxidation levels in damaged tissues

Retinal conditions require systemic administration (injection) accepting barrier penetration limitations
